urology
Haematuria Assessment
Visible and non-visible haematuria investigation pathway — 2WW vs routine
Source: NICE NG12 / BAUS 2020
Step 1 of ~8
info
Haematuria Assessment
Visible haematuria (VH) is significant until proven otherwise. Non-visible haematuria (NVH): confirmed on ≥2 of 3 dipstick tests (exclude UTI first).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methylene Blue · Guanylate Cyclase / Nitric Oxide Pathway Inhibitor
- Sodium phenylbutyrate · Ammonia scavenger (alternative pathway)
- Marstacimab · Anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody
- Glasdegib (Specialist drug) · Hedgehog pathway inhibitor
- Vismodegib (Specialist drug) · Hedgehog pathway (SMO) inhibitor
Decision support only. Always apply local guidelines and clinical judgement.